{"@type": "dcat:Dataset", "accessLevel": "public", "contactPoint": {"@type": "vcard:Contact", "fn": "Valerie", "hasEmail": "mailto:no-reply@data.ct.gov"}, "description": "This dataset provides the prescription count for controlled substances, non-controlled substances, opioids, benzodiazepine, stimulant, gabapentin, & naloxone dispensations in the state. It only includes dispensations to CT residents reported to the CT Prescription Monitoring & Reporting System (CPMRS). \n\nControlled substances are those that have been categorized as schedule II - V.\n\nOpioid Agonists are generally used to treat moderate to severe pain typically associated with injury, surgery, or various health conditions.\n\nOpioid partial agonists bind to opioid receptor sites and works slowly in the body to help prevent withdrawals and reduce cravings for opioid drugs. Opiate partial agonists are used to treat opioid use disorder. Prescription opioid partial agonists include buprenorphine, butorphanol, and pentazocine.\n\nBenzodiazepines slow down the central nervous system, and often used to relieve anxiety and muscle spasms, as well as reduce seizures.\n\nStimulants increase alertness and energy, enhancing focus. Stimulants are commonly used to treat attention-deficit hyperactivity disorders (ADHD).\n\nGabapentin is an anticonvulsant or antiepileptic drug, used to treat seizures and relieve pain.\n\nNaloxone is used to quickly reverse an opioid overdose. Naloxone is an opioid antagonist, and works by attaching to opioid receptors, to reverse and block the effects of other opioids.", "distribution": [{"@type": "dcat:Distribution", "downloadURL": "https://data.ct.gov/api/views/iqsu-irmt/rows.csv?accessType=DOWNLOAD", "mediaType": "text/csv"}, {"@type": "dcat:Distribution", "describedBy": "https://data.ct.gov/api/views/iqsu-irmt/columns.rdf", "describedByType": "application/rdf+xml", "downloadURL": "https://data.ct.gov/api/views/iqsu-irmt/rows.rdf?accessType=DOWNLOAD", "mediaType": "application/rdf+xml"}, {"@type": "dcat:Distribution", "describedBy": "https://data.ct.gov/api/views/iqsu-irmt/columns.json", "describedByType": "application/json", "downloadURL": "https://data.ct.gov/api/views/iqsu-irmt/rows.json?accessType=DOWNLOAD", "mediaType": "application/json"}, {"@type": "dcat:Distribution", "describedBy": "https://data.ct.gov/api/views/iqsu-irmt/columns.xml", "describedByType": "application/xml", "downloadURL": "https://data.ct.gov/api/views/iqsu-irmt/rows.xml?accessType=DOWNLOAD", "mediaType": "application/xml"}], "identifier": "https://data.ct.gov/api/views/iqsu-irmt", "issued": "2023-12-01", "keyword": ["pmp", "naloxone", "prescription monitoring program", "benzodiazepine", "connecticut prescription monitoring program", "stimulant", "controlled substances", "gabapentin", "opioid"], "landingPage": "https://data.ct.gov/d/iqsu-irmt", "modified": "2026-02-20", "publisher": {"@type": "org:Organization", "name": "data.ct.gov"}, "theme": ["Health and Human Services"], "title": "Prescription Monitoring Program: Prescription Dispensations"}